Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus-8, is the etiological agent of Kaposi's sarcoma, as well as rare lymphoproliferative disorders.

Cite this: Kaposi's Sarcoma in the Pediatric Population: The Critical Need for a Tissue Diagnosis - Medscape - May 01, 2009. Abstract and Case Report Discussion ...

A downside to CT screening for lung cancer is that the test can have false-positive findings that lead to unnecessary medical procedures. For instance, your doctor might spot a nodule that looks ...

In Germany as well, they are now one of the most common radiological examinations: 800,000 lung CT scans were done in 2009, compared to 1.3 million in 2020.

Moleculin Releases On-Demand KOL Webcast to Discuss Data from its Phase 1B/2 Study of Annamycin for the Treatment of Soft Tissue Sarcoma (STS) Lung Metastases (MB-107) Moleculin Biotech, Inc. Thu ...

Moleculin Biotech has announced encouraging topline efficacy outcomes from its US Phase IB/II trial, MB-107, of Annamycin for soft tissue sarcoma lung metastases (STS lung mets) treatment. The ...

positive topline efficacy results from its completed U.S. Phase 1B/2 clinical trial evaluating Annamycin for the treatment of Soft Tissue Sarcoma Lung Metastases (“STS lung mets”) (MB-107).

The elusive and enigmatic origin of AIDS-associated Kaposi's sarcoma (AIDS-KS) makes it a complex tumor and therefore difficult to treat. Here we demonstrate that AIDS-KS cells express surface ...

Long COVID destroys teenage lungs in ways doctors never saw - silent damage persists months after mild infections in developing adolescents.

HOUSTON, June 04, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin” or the "Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates ...

Moleculin Reports Positive Topline Efficacy Results From U.S. Phase 1B/2 Clinical Trial Evaluating Annamycin For The Treatment Of Soft Tissue Sarcoma Lung Metastases (MB-107) Date 2025-06-04 08:46:39 ...